COMPUTER-AIDED SIMULATION ANALYSIS (CASA) IN ORDER TO TEST COST-EFFECTIVENESS OF DRUGS USING THE EXAMPLE OF CEFTRIAXONE (ROCEPHIN(R))

被引：0
|
作者：
BERGEMANN, R
BRANDT, A
NAWRATH, T
RICHTER, A
SIEGRIST, W
SORENSON, F
机构：
来源：
LECTURE NOTES IN ECONOMICS AND MATHEMATICAL SYSTEMS | 1992年 / 376卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：221 / 226
页数：6
相关论文
共 50 条
  • [21] AN INTERACTIVE COMPUTER-SYSTEM FOR FORMULARY MANAGEMENT USING COST-EFFECTIVENESS ANALYSIS
    LEE, JH
    GLICK, HA
    KINOSIAN, B
    SCHULMAN, KA
    M D COMPUTING, 1995, 12 (01): : 59 - &
  • [22] DEVELOPMENT OF A FRAMEWORK FOR COST-EFFECTIVENESS ANALYSIS COHORT SIMULATION USING AN ORDINARY DIFFERENTIAL EQUATION SOLVER ALGORITHM IN R
    Frederix, G. W.
    van Hasselt, J. G.
    Severens, J. L.
    Hovels, A. M.
    Huitema, A. D.
    Raaijmakers, J. A.
    Schellens, J. H.
    VALUE IN HEALTH, 2012, 15 (07) : A468 - A468
  • [23] A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus
    Chen, THH
    Yen, MF
    Tung, TH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 54 : S37 - S42
  • [24] Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis
    MacPherson, Peter G.
    Webb, Emily H.
    Kamchedzera, Wala T.
    Joekes, Elizabeth M.
    Mjoli, Gugu
    Lalloo, David
    Divala, Titus
    Choko, Augustine
    Burke, Rachael L.
    Maheswaran, Hendramoorthy
    Pai, Madhukar
    Squire, S. Bertel
    Nliwasa, Marriott
    Corbett, Elizabeth
    PLOS MEDICINE, 2021, 18 (09)
  • [25] Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?
    Maarten J. Postma
    Declan Noone
    Mark H. Rozenbaum
    John A. Carter
    Marc F. Botteman
    Elisabeth Fenwick
    Louis P. Garrison
    Orphanet Journal of Rare Diseases, 17
  • [26] Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?
    Postma, Maarten J.
    Noone, Declan
    Rozenbaum, Mark H.
    Carter, John A.
    Botteman, Marc F.
    Fenwick, Elisabeth
    Garrison, Louis P.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [27] A COMPARISON OF R PACKAGES FOR PREDICTION AND SIMULATION OF MULTI-STATE MODELS FOR COST-EFFECTIVENESS ANALYSIS
    Incerti, D.
    Jansen, J. P.
    VALUE IN HEALTH, 2019, 22 : S322 - S322
  • [28] Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study (FEB, 10.1055/a-2532-9282, 2024)
    Halvorsen, Natalie
    Barua, Ishita
    Kudo, Shin-ei
    Gulati, Shraddha
    Misawa, Masashi
    Mori, Kensaku
    Hayee, Bu'Hussain
    Olabintan, Olaolu
    Nilsen, Jens Aksel
    Frigstad, Svein Oskar
    East, James E.
    Rastogi, Amit
    Hassan, Cesare
    Kalager, Mette
    Loberg, Magnus
    Holme, Oyvind
    Haji, Amyn
    Bretthauer, Michael
    Mori, Yuichi
    ENDOSCOPY, 2025,
  • [29] Which test is best for Helicobacter pylori?: A cost-effectiveness model using decision analysis
    Elwyn, Glyn
    Taubert, Mark
    Davies, Shan
    Brown, Ginevra
    Allison, Miles
    Phillips, Ceri
    BRITISH JOURNAL OF GENERAL PRACTICE, 2007, 57 (538) : 401 - 403
  • [30] Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation
    Freitag, Bettina
    Uncovska, Marie
    Meister, Sven
    Prinz, Christian
    Fehring, Leonard
    NPJ DIGITAL MEDICINE, 2024, 7 (01):
12345